Topic 435 - physiological compression therapy to augment lymphatic function and improve lymphedema resolution.
Ended Definitive Contract Awarded Last action
- Contract number
- 75N91022C00024
- Awardee
-
Lymphatech, Inc. UEI W7JWEZ412CR3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $400,000
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals Pre-Solicitation · PHS20221 · Posted Jul 12, 2021
- Contract value 100% obligated
- $400,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 6 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Atlanta, GA 30308, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $400,000 |
About this award
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Lymphatech, Inc., a minority-owned, for-profit small business. The $400,000.00 firm-fixed-price contract is for research and development of physiological compression therapy to augment lymphatic function and improve lymphedema resolution, which is related to the NIH's cancer treatment and research mission. The contract work is to be performed in Atlanta, Georgia and has a completion date of December 14, 2023.
Quick answers
Who was awarded contract 75N91022C00024?
75N91022C00024 was awarded to Lymphatech, Inc. by National Cancer Institute (National Institutes of Health) on August 25, 2022.
How much is contract 75N91022C00024 worth?
The government has obligated $400,000 on 75N91022C00024.
Was contract 75N91022C00024 competed?
The extent of competition for 75N91022C00024 was full and open competition after exclusion of sources. The government received 6 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award